NERV Company Profile and Key Details

Q: Who are the executives of NERV?

Dr. Remy Luthringer Ph.D.Executive Chairman & Chief Executive OfficerMr. Geoffrey Robin Race F.C.M.A., FCMA, M.B.A., MBAPresMr. Frederick W. Ahlholm CPA, CPASenior Vice President, Chief Financial Officer & Sec.Mr. Joseph ReillySenior Vice President & Chief Operating OfficerMr. William B. BoniVice President of Investor Relations & Corporation CommunicationsProf. Michael Davidson M.D.Chief Medical OfficerDr. Ramana Kuchibhatla Ph.D.Senior Vice President and Head of R&D

NASDAQ : NERV

Minerva Neurosciences

$4.15

-0.01-0.24%

At Close 4:00 PM

61.82

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Minerva Neurosciences, Inc. (NERV) stock declined over -0.24%, trading at $4.15 on NASDAQ, down from the previous close of $4.16. The stock opened at $4.22, fluctuating between $4.13 and $4.37 in the recent session.

Stock Snapshot

4.16

Prev. Close

193.34M

Market Cap

4.13

Day Low

-0.97

P/E Ratio

-4.29

EPS (TTM)

-2.23

Cash Flow per Share

4.22

Open

46.59M

Number of Shares

4.37

Day High

77.74%

Free Float in %

-3.76

Book Value

135.95K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Sep 11, 2026	4.24	4.38	4.13	4.15	135.95K
Sep 10, 2026	4.10	4.24	4.10	4.16	72.1K
Sep 09, 2026	4.35	4.43	4.10	4.12	112.06K
Sep 08, 2026	4.40	4.46	4.32	4.37	91.54K
Sep 04, 2026	4.66	4.80	4.42	4.43	78.44K
Sep 03, 2026	4.53	4.72	4.39	4.69	151.22K
Sep 02, 2026	4.50	4.60	4.46	4.48	82.83K
Sep 01, 2026	4.53	4.64	4.46	4.48	90.77K
Aug 31, 2026	4.82	4.89	4.52	4.56	116.33K
Aug 28, 2026	5.17	5.30	4.82	4.84	135.73K
Aug 27, 2026	5.43	5.43	5.03	5.13	89.9K
Aug 26, 2026	5.01	5.63	4.98	5.43	383.96K
Aug 25, 2026	4.85	5.20	4.71	5.00	114.28K
Aug 24, 2026	4.79	4.94	4.64	4.81	111.85K
Aug 21, 2026	4.79	5.07	4.79	4.84	106.45K
Aug 20, 2026	4.76	4.88	4.64	4.79	133.14K
Aug 19, 2026	4.62	4.96	4.60	4.79	2.28M
Aug 18, 2026	4.42	4.56	4.34	4.54	100.72K
Aug 17, 2026	4.54	4.58	4.40	4.42	110.02K
Aug 14, 2026	4.42	4.79	4.30	4.58	340.01K

Contact Details

Burlington, MA 01803

United States

https://www.minervaneurosciences.com 617 600 7373

About Company

Minerva Neurosciences, Inc. functions as a biopharmaceutical firm in the clinical development stage, primarily dedicated to uncovering and bringing to market novel therapeutic options for disorders affecting the central nervous system. Its portfolio of experimental treatments notably features roluperidone, an investigational drug aimed at managing schizophrenia, alongside MIN-301, a soluble recombinant variant of the neuregulin-1b1 protein, which is being explored for its potential in treating Parkinson's disease and various other neurodegenerative conditions. The company has a contractual licensing agreement with Mitsubishi Tanabe Pharma Corporation, authorizing the worldwide development, distribution, and import of roluperidone, with the explicit exclusion of the Asian continent. Established in 2007, this organization initially operated as Cyrenaic Pharmaceuticals, Inc. before undergoing a name change to Minerva Neurosciences, Inc. in 2013. Its corporate headquarters are located in Waltham, Massachusetts.

Stock Peers

ARGX

0.35+0.04%

argenx SE$984.39 REGN

-11.77-1.48%

Regeneron Pharmaceuticals, Inc.$781.49 MDGL

1.37+0.26%

Madrigal Pharmaceuticals, Inc.$534.49 VRTX

0.88+0.17%

Vertex Pharmaceuticals Incorporated$515.44 UTHR

-6.75-1.34%

United Therapeutics Corporation$497.11 KRYS

1.45+0.42%

Krystal Biotech, Inc.$347.00 ONC

4.71+1.38%

BeOne Medicines AG$346.51 PRAX

-3.99-1.18%

Praxis Precision Medicines, Inc.$334.58 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 LGND

-4.78-1.65%

Ligand Pharmaceuticals Incorporated$284.47

Frequently Asked Questions

What is the current Minerva Neurosciences, Inc. (NERV) stock price?

Minerva Neurosciences, Inc. (NASDAQ: NERV) stock price is $4.15 in the last trading session. During the trading session, NERV stock reached the peak price of $4.37 while $4.13 was the lowest point it dropped to. The percentage change in NERV stock occurred in the recent session was -0.24% while the dollar amount for the price change in NERV stock was - $0.01.

NERV's industry and sector of operation?

The NASDAQ listed NERV is part of Biotechnology industry that operates in the broader Healthcare sector. Minerva Neurosciences, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of NERV?

Dr. Remy Luthringer Ph.D.
Executive Chairman & Chief Executive Officer
Mr. Geoffrey Robin Race F.C.M.A., FCMA, M.B.A., MBA
Pres
Mr. Frederick W. Ahlholm CPA, CPA
Senior Vice President, Chief Financial Officer & Sec.
Mr. Joseph Reilly
Senior Vice President & Chief Operating Officer
Mr. William B. Boni
Vice President of Investor Relations & Corporation Communications
Prof. Michael Davidson M.D.
Chief Medical Officer
Dr. Ramana Kuchibhatla Ph.D.
Senior Vice President and Head of R&D

How NERV did perform over past 52-week?

NERV's closing price is 115.03% higher than its 52-week low of $1.93 where as its distance from 52-week high of $12.46 is -66.69%.

How many employees does NERV have?

Number of NERV employees currently stands at 7.

Link for NERV official website?

Official Website of NERV is: https://www.minervaneurosciences.com

How do I contact NERV?

NERV could be contacted at phone 617 600 7373 and can also be accessed through its website. NERV operates from 1500 District Avenue, Burlington, MA 01803, United States.

How many shares of NERV are traded daily?

NERV stock volume for the day was 135.95K shares. The average number of NERV shares traded daily for last 3 months was 256.86K.

What is the market cap of NERV currently?

The market value of NERV currently stands at $193.34M with its latest stock price at $4.15 and 46.59M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	7
Beta	-0.11
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	7
Beta	-0.11
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

NERV Company Profile and Key Details

Minerva Neurosciences

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Company Overview

Dividend & Fair Value

Technical Performance

Shareholding & Insider Activity

Earnings & Analyst Outlook

Financial & Profitability Overview

Quarterly Financial Highlights

Valuation Metrics

Price Forecast & Outlook

Key Takeaways